Major Program
Phase 0 I II Cancer Prevention Clinical Trials Program
Research Group
Breast and Gynecologic Cancer
Sponsor
University of Kansas Medical Center
Status
Completed
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT00853996
This phase II trial is studying how well acolbifene works in preventing cancer in premenopausal women at high risk of breast cancer. Chemoprevention is the use of certain drugs to keep cancer from forming. The use of acolbifene may stop cancer from growing or coming back.
Intervention
acolbifene hydrochloride
Condition
Breast Cancer
Investigators
Carol Fabian